BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22139575)

  • 1. Increased DNA methylation of neuropsychiatric genes occurs in borderline personality disorder.
    Dammann G; Teschler S; Haag T; Altmüller F; Tuczek F; Dammann RH
    Epigenetics; 2011 Dec; 6(12):1454-62. PubMed ID: 22139575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant DNA Methylation of rDNA and PRIMA1 in Borderline Personality Disorder.
    Teschler S; Gotthardt J; Dammann G; Dammann RH
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26742039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder.
    Teschler S; Bartkuhn M; Künzel N; Schmidt C; Kiehl S; Dammann G; Dammann R
    PLoS One; 2013; 8(12):e84180. PubMed ID: 24367640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder.
    Thomas M; Knoblich N; Wallisch A; Glowacz K; Becker-Sadzio J; Gundel F; Brückmann C; Nieratschker V
    Clin Epigenetics; 2018 Aug; 10(1):109. PubMed ID: 30134995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential COMT DNA methylation in patients with Borderline Personality Disorder: Genotype matters.
    Thomas M; Banet N; Wallisch A; Glowacz K; Becker-Sadzio J; Gundel F; Nieratschker V
    Eur Neuropsychopharmacol; 2019 Nov; 29(11):1295-1300. PubMed ID: 31587837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder.
    Martín-Blanco A; Ferrer M; Soler J; Salazar J; Vega D; Andión O; Sanchez-Mora C; Arranz MJ; Ribases M; Feliu-Soler A; Pérez V; Pascual JC
    J Psychiatr Res; 2014 Oct; 57():34-40. PubMed ID: 25048180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline personality disorder and childhood maltreatment: a genome-wide methylation analysis.
    Prados J; Stenz L; Courtet P; Prada P; Nicastro R; Adouan W; Guillaume S; Olié E; Aubry JM; Dayer A; Perroud N
    Genes Brain Behav; 2015 Feb; 14(2):177-88. PubMed ID: 25612291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide methylation study reveals X chromosome and childhood trauma methylation alterations associated with borderline personality disorder.
    Arranz MJ; Gallego-Fabrega C; Martín-Blanco A; Soler J; Elices M; Dominguez-Clavé E; Salazar J; Vega D; Briones-Buixassa L; Pascual JC
    Transl Psychiatry; 2021 Jan; 11(1):5. PubMed ID: 33414392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.
    Carrard A; Salzmann A; Malafosse A; Karege F
    J Affect Disord; 2011 Aug; 132(3):450-3. PubMed ID: 21453976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of BDNF in women with bulimic eating syndromes: associations with childhood abuse and borderline personality disorder.
    Thaler L; Gauvin L; Joober R; Groleau P; de Guzman R; Ambalavanan A; Israel M; Wilson S; Steiger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():43-9. PubMed ID: 24801751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted bisulfite sequencing: A novel tool for the assessment of DNA methylation with high sensitivity and increased coverage.
    Moser DA; Müller S; Hummel EM; Limberg AS; Dieckmann L; Frach L; Pakusch J; Flasbeck V; Brüne M; Beygo J; Klein-Hitpass L; Kumsta R
    Psychoneuroendocrinology; 2020 Oct; 120():104784. PubMed ID: 32673938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of APBA3 and MCF2 in borderline personality disorder: Potential biomarkers for response to psychotherapy.
    Knoblich N; Gundel F; Brückmann C; Becker-Sadzio J; Frischholz C; Nieratschker V
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):252-263. PubMed ID: 29274998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the dopamine D2 receptor (DRD2) gene promoter in women with a bulimia-spectrum disorder: associations with borderline personality disorder and exposure to childhood abuse.
    Groleau P; Joober R; Israel M; Zeramdini N; DeGuzman R; Steiger H
    J Psychiatr Res; 2014 Jan; 48(1):121-7. PubMed ID: 24157248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the glucocorticoid receptor gene promoter in bulimic women: associations with borderline personality disorder, suicidality, and exposure to childhood abuse.
    Steiger H; Labonté B; Groleau P; Turecki G; Israel M
    Int J Eat Disord; 2013 Apr; 46(3):246-55. PubMed ID: 23417893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study.
    Ni X; Chan D; Chan K; McMain S; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):128-33. PubMed ID: 19032968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of serotonin receptor 2A gene (HTR2A): association study with autism spectrum disorder in the Indian population and investigation of the gene expression in peripheral blood leukocytes.
    Guhathakurta S; Singh AS; Sinha S; Chatterjee A; Ahmed S; Ghosh S; Usha R
    Neurochem Int; 2009 Dec; 55(8):754-9. PubMed ID: 19647026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the genetics and epigenetics of bulimia nervosa/bulimia spectrum disorder and comorbid borderline personality disorder (BN/BSD-BPD): a systematic review.
    McDonald S
    Eat Weight Disord; 2019 Oct; 24(5):799-814. PubMed ID: 31119586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered DNA methylation of the
    Li S; Zong L; Hou Y; Zhang W; Zhou L; Yang Q; Wang L; Jiang W; Li Q; Huang X; Ning Y; Wen Z; Zhao C
    Epigenomics; 2019 May; 11(6):581-586. PubMed ID: 31066577
    [No Abstract]   [Full Text] [Related]  

  • 19. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
    Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene.
    Perroud N; Salzmann A; Prada P; Nicastro R; Hoeppli ME; Furrer S; Ardu S; Krejci I; Karege F; Malafosse A
    Transl Psychiatry; 2013 Jan; 3(1):e207. PubMed ID: 23422958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.